Accenture (ACN) CEO RSU Anti-Dilution Grant Increases Ownership to 8,288

Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), received restricted share units (RSUs) on 08/15/2025 as recorded on this Form 4.

Rhea-AI Filing Summary

Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), received restricted share units (RSUs) on 08/15/2025 as recorded on this Form 4. The filing shows an acquisition coded as "A" related to anti-dilution adjustments for previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists a unit price of $247.57 and indicates 8,288 Class A ordinary shares beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on behalf of Ms. Sweet on 08/18/2025.

Insights

Corporate Governance Expert

TL;DR: Routine dividend-related RSU anti-dilution grant to CEO; governance-normal, limited market impact.

The filing documents a non-derivative acquisition of restricted share units issued under anti-dilution provisions tied to a cash dividend. This is a standard administrative adjustment to preserve the economic position of prior equity awards after a dividend distribution. The transaction increases reported beneficial ownership to 8,288 Class A ordinary shares, reflecting grant mechanics rather than new cash compensation activity. No departures from typical insider-reporting practice are indicated.

Securities Analyst

TL;DR: Transaction is administrative (RSU adjustment); not a material trading signal for investors.

The Form 4 shows an acquisition coded "A" with an indicated price of $247.57 and a note that the RSUs were granted pursuant to anti-dilution provisions following a cash dividend. Such anti-dilution RSU grants are corrective in nature to maintain prior award value after distributions. The report increases direct beneficial ownership to 8,288 shares but provides no indication of cash purchase or exercise economics beyond the listed per-share amount. Impact on capital structure and dilution appears immaterial from the data provided.

Insider Trade Summary

Grant/Award: 24 shares

Grant/Award 1 txn

Insider Sweet Julie Spellman

Role Chair and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	24	$247.57	$6K

Holdings After Transaction: Class A ordinary shares — 8,288 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Julie Spellman Sweet report on Form 4 for ACN?

The Form 4 reports an acquisition (code A) of restricted share units (RSUs) on 08/15/2025 related to anti-dilution provisions following a cash dividend.

How many Accenture shares does Julie Spellman Sweet beneficially own after the transaction?

The filing shows 8,288 Class A ordinary shares beneficially owned following the reported transaction.

What was the reported per-share amount in the Form 4?

The Form 4 lists a price of $247.57 associated with the reported RSU transaction.

Why were the RSUs granted according to the filing?

The filing states the RSUs were granted pursuant to the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend.

When was the Form 4 signed and by whom?

The Form 4 was signed on behalf of Julie Spellman Sweet by an attorney-in-fact (Danika Haueisen) on 08/18/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2025 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweet Julie Spellman

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/15/2025		A		24(1)	A	$247.57	8,288	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.